Brief: Alligator Bioscience Gets Granted U.S. Patent For Cancer Treatment Antibody
16/01/2024 11:44
Jan 16 (Reuters) - Alligator Bioscience AB ATORX.ST :
* ALLIGATOR BIOSCIENCE GRANTED FIRST U.S. PATENT FOR
NEO-X-PRIME™
BISPECIFIC ANTIBODY ATOR-4066 FOR CANCER TREATMENT
Source text for Eikon: ID:nMFN8MnWmf
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln